© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Michael Barnea

Michael Barnea

Micky, the firm’s Founding and Managing Partner, is recognized as one of Israel’s leading corporate lawyers. His diverse practice encompasses corporate, securities, technology, and cross-border matters.

Micky has earned an excellent reputation for working with private and public companies on securities offerings, fundraising, M&A transactions, transfers of control, and reorganizations.

 

Micky is greatly respected as a legal advisor to public companies traded on both Israeli and foreign stock exchanges, as well as to foreign investors with stakes in Israeli publicly-traded companies.

 

In the technology sphere, Micky counsels a variety of early and later-stage companies, as well as leading venture capital, corporate venture, and private-equity investors. He also oversees prominent cross-border technology-related transactions.

 

Micky is a well-known figure in the Israeli hi-tech ecosystem. He lectures on a regular basis to various Israeli accelerators and incubators, in addition to serving as a mentor for young entrepreneurs.

 

Micky has consistently been ranked in the prestigious Chambers and Partners directory as a leading lawyer in the Corporate/M&A and TMT practice area. The guide describes him as “really brilliant and very straightforward. Problem solver.” The guide also ranked him as a leading lawyer in the field of Private Wealth Law. 

 

The IFLR1000 directory also steadily ranks Micky for his work in the Capital Markets: Equity and M&A sector. The ILFR1000 pronounced him as “very practical and incisive and always constructive with his advice.” 

 

In addition to his work with the firm, Micky was appointed as the Middle East Liaison Officer of the IBA Law Firm Management Committee.

Education:


Tel Aviv University (LL.B.) 1992




Admission:


Member of Israel Bar Association since 1993




News and updates - Michael Barnea:


June 3, 2019

Barnea Represented Johnson & Johnson Innovation in an Investment Round in Techsomed

Micky Barnea, Ariella Dreyfuss, Itay Gura, Mayer Winkler, and Ido Freund represented Johnson & Johnson Innovation in an investment round in the Israeli medtech startup Techsomed Medical Technologies Ltd. Founded in 2012, Techsomed has developed an image analysis system that helps track tissue response to thermal ablation, the process of destroying tumors using extreme heat or cold. Techsomed intends to use the funding toward receiving regulatory approval in the US, Europe, and Japan.

 

JJDC led the company's current round of financing, which included both former and new investors, such as Screen Holdings, the Alfred Mann Institute at the Technion (AMIT), NextLeap Ventures, and Axil Capital.

May 6, 2019

Redomiciling an Israeli Public Company to Delaware

On April 12, 2019, Arcturus Therapeutics Ltd., an Israeli public company traded on NASDAQ, published in the United States a prospectus and proxy statement (convening a general meeting of shareholders of the company). Publishing the prospectus is an advanced step toward completing an arrangement between the company and its shareholders.

March 20, 2019

Barnea Represented Danel Ltd. in the Acquisition of Levinger Group

Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.

See all news of Michael Barnea >

Enter your email for newsletter sign up: